Advertisement

Search Results

Advertisement



Article Topics

Your search for Chau T. Dang, MD, Pedram Razavi, MD, PhD, Sarat Chandarlapaty, MD, PhD, and Shanu Modi, MD matches 1 pages

Showing 1 - 1


breast cancer

Trastuzumab Emtansine in Treatment of Residual Breast Cancer After Neoadjuvant Therapy: Who Will Benefit?

The discovery of trastuzumab has been revolutionary in the treatment of HER2-positive breast cancer, both in the metastatic and early-stage settings.1-6 This cannot be disputed. In the early-stage setting, the addition of trastuzumab to standard chemotherapy has led to a 50% gain in...

Advertisement

Advertisement



;
Advertisement